Endocrine Disorders and Delayed Puberty

Chapter

Abstract

Abnormal puberty is a common presenting complaint for pediatric endocrinology and gynecology practices. In girls, normal puberty may begin as early as 8 years. Though most Caucasian females develop breast tissue after the age of 8 years, race plays a role in pubertal timing, as it is more common for African American and Mexican-American females to begin puberty at an earlier age. Activation of the hypothalamic pituitary ovarian axis marks the beginning of puberty. Puberty is initiated in the hypothalamus by an increase in GnRH pulsatility and the subsequent development of the neuroendocrine system allows for changes in gonadal hormone stimulatory and inhibitory effects. Gonadotropins secreted by the pituitary in response to GnRH rise gradually. In early puberty, LH increases at night during sleep but it loses its diurnal pattern near menarche. These hormonal changes of the hypothalamus and pituitary influence the ovary, allowing estrogen levels to gradually rise to adult ranges. Rising estrogen levels account for the development of secondary sexual characteristics and ultimately stimulate endometrial growth allowing for menarche to occur.

Keywords

Puberty Pubertal delay Tanner staging Menarche Primary amenorrhea Gonadotropins Estradiol Hypergonadotropic hypogonadism Primary ovarian failure Primary ovarian insufficiency Hypothyroidism Hashimoto’s thyroiditis Hypogonadotropic hypogonadism Hyperprolactinemia 

Abbreviations

ACTH

Adrenocorticotropic hormone

ART

Assisted reproductive technology

BMI

Body mass index

CBC

Complete blood count

CMP

Comprehensive Metabolic Panel

DHEAS

Dehydroepiandrosterone sulfate

FSH

Follicle stimulating hormone

GnRH

Gonadotropin-releasing hormone

HCG

Human chorionic gonadotropin

IVF

In vitro fertilization

LH

Luteinizing hormone

MRI

Magnetic resonance imaging

OCP

Oral contraceptive pill

POF

Primary ovarian failure

POI

Primary ovarian insufficiency

PRL

Prolactin

TBG

Thyroid-binding globulin

TSH

Thyroid stimulating hormone

T4

Thyroxine

TS

Turner syndrome

References

  1. 1.
    Nakamoto JM. Myths and variations in normal pubertal development. Western J Med. 2000;172:182–5.CrossRefGoogle Scholar
  2. 2.
    Bordini B, Rosenfield R. Normal pubertal development: Part I: the endocrine basis of puberty. Pediatr Rev. 2011;32:223–9.CrossRefPubMedGoogle Scholar
  3. 3.
    Stang J, Story M. Understanding adolescent eating behaviors. In: Stang J, Story M, editors. Guidelines for adolescent nutrition services. Minneapolis, MN: University of Minnesota School of Public Health; 2005. p. 1–8.Google Scholar
  4. 4.
    Bordini B, Rosenfield R. Normal pubertal development: Part II: clinical aspects of puberty. Pediatr Rev. 2011;37:281–91.CrossRefGoogle Scholar
  5. 5.
    Rosenfield R, Cooke D, Radovick S. The ovary and female maturation. In: Sperling M, editor. Pediatric endocrinology. 3rd ed. Pittsburgh: Saunders; 2008. p. 564–78.Google Scholar
  6. 6.
    Dwyer A, Phan-Hug F, Hauschild M, Elowe-Gruau E, Pitteloud N. Hypogonadism in adolescence. Eur J Endocrinol. 2015;173(1):R15–24.CrossRefPubMedGoogle Scholar
  7. 7.
    Medicine TPCotASfR. Current evaluation of amenorrhea. Fertil Steril. 2008;90:S219–S25.Google Scholar
  8. 8.
    Garel L, Dubois J, Grignon A, Filiatrault D, Vliet GV. US of the pediatric female pelvis: a clinical perspective. Radiographics. 2001;21:1393–407.CrossRefPubMedGoogle Scholar
  9. 9.
    Pavlik EJ, DePriest PD, Gallion HH, et al. Ovarian volume related to age. Gynecol Oncol. 2000;77:410–2.CrossRefPubMedGoogle Scholar
  10. 10.
    Nelson L. Primary ovarian insufficiency. New Engl J Med. 2009;360:606–14.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Menopause. American Congress of Obstetricians and Gynecologists, 2013. Accessed February 26, 2015, at http://www.acog.org/Patients/FAQs/Menopause.
  12. 12.
    American Congress of Obstetricians and Gynecologists. Primary ovarian insufficiency in adolescents and young women. 2014. Accessed February 26, 2015, at http://www.acog.org/%20Resources-And-Publications/Committee-Opinions/Committee-on-Adolescent-Health-Care/Primary-Ovarian-Insufficiency-in-Adolescents-and-Young-Women.
  13. 13.
    Carr BR. Disorders of the ovaries and female reproductive tract. In: Wilson JD et al., editors. William’s textbook of endocrinology. 9th ed. Philadelphia: W.B. Saunders; 1998. p. 485.Google Scholar
  14. 14.
    Rafique S, Sterling E, Nelson L. A new approach to primary ovarian insufficiency. Obstet Gynecol Clin North Am. 2012;39:567–86.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Groff A, Covington S, Halverson L, et al. Assessing the emotional needs of women with spontaneous premature ovarian failure. Fertil Steril. 2005;83:1734–41.CrossRefPubMedGoogle Scholar
  16. 16.
    Gravholt C. Epidemiological, endocrine and metabolic features in Turner syndrome. Eur J Endocrinol. 2004;151:657–87.CrossRefPubMedGoogle Scholar
  17. 17.
    Simon J. What's new in hormone replacement therapy: Focus on transdermal estradiol and micronized progesterone. Climacteric. 2012;15:3–10.CrossRefPubMedGoogle Scholar
  18. 18.
    Lignières B. Oral micronized progesterone. Clin Ther. 1999;21:41–60.CrossRefPubMedGoogle Scholar
  19. 19.
    Sherif K. Benefits and risks of oral contraceptives. Am J Obstet Gynecol. 1999;180:S343–S8.CrossRefPubMedGoogle Scholar
  20. 20.
    Fehr AD, Mounsey A, Yates JE, Flake D. Cardiovascular risks of combined oral contraceptive use. Am Fam Physician. 2012;86:1–2.PubMedGoogle Scholar
  21. 21.
    Pediatrics AAo. Bone densitometry in children and adolescents. Pediatrics. 2011;127:189–94.CrossRefGoogle Scholar
  22. 22.
    Etherington J, Harris PA, Nandra D, et al. The effect of weight-bearing exercise on bone mineral density: a study of female ex-elite athletes and the general population. J Bone Miner Res. 1996;11:1333–8.CrossRefPubMedGoogle Scholar
  23. 23.
    Eunice Kennedy Shriver National Institute of Child Health and Human Development. What are the treatments for POI? 2013. Accessed February 26, 2015, at https://www.nichd.nih.gov/health/topics/poi/conditioninfo/Pages/treatments.aspx.
  24. 24.
    Shelling AN. Premature ovarian failure. Reproduction. 2010;140:633–41.CrossRefPubMedGoogle Scholar
  25. 25.
    Bidet M, Bachelot A, Touraine P. Premature ovarian failure: predictability of intermittent function and response to ovulation induction agents. Curr Opin Obstet Gynecol. 2008;20:416–20.CrossRefPubMedGoogle Scholar
  26. 26.
    Khandelwal D, Tandon N. Overt and subclinical hypothyroidism: who to treat and how. Drugs. 2012;72:17–33.CrossRefPubMedGoogle Scholar
  27. 27.
    Almandoz J, Gharib H. Hypothyroidism: etiology, diagnosis, and management. Med Clin North Am. 2012;96:203–21.CrossRefPubMedGoogle Scholar
  28. 28.
    National Institute of Diabetes and Digestive and Kidney Disorders. Hypothyroidism. 2013. Accessed February 26, 2015, at http://www.niddk.nih.gov/health-information/health-topics/endocrine/hypothyroidism/Pages/fact-sheet.aspx.
  29. 29.
    Yen PM. Physiological and molecular basis of thyroid hormone action. Physiol Rev. 2001;81:1097–142.PubMedGoogle Scholar
  30. 30.
    Weber G, Vigone M, Chiumello G. Thyroid function and puberty. J Pediatr Endocrinol Metab. 2003;16:S253–7.Google Scholar
  31. 31.
    Koutras D. Disturbances of menstruation in thyroid disease. Ann N Y Acad Sci. 1997;816:280–4.CrossRefPubMedGoogle Scholar
  32. 32.
    Indumathi C, Bantwal G, Patil M. Primary hypothyroidism with precocious puberty and bilateral cystic ovaries. Indian J Pediatr. 2007;74:781–3.CrossRefPubMedGoogle Scholar
  33. 33.
    Dijkstra G, de Rooij DG, de Jong FH, van den Hurk R. Effect of hypothyroidism on ovarian follicular development, granulosa cell proliferation and peripheral hormone levels in the prepubertal rat. Eur J Endocrinol. 1996;134:649–54.CrossRefPubMedGoogle Scholar
  34. 34.
    Krassas GE. Thyroid disease and female reproduction. Fertil Steril. 2000;74:1063–70.CrossRefPubMedGoogle Scholar
  35. 35.
    Kakuno Y, Amino N, Kanoh M, Kawai M, Fujiwara M. Menstrual disturbances in various thyroid diseases. Endocr J. 2010;57:1017–22.CrossRefPubMedGoogle Scholar
  36. 36.
    Krassas G, Pontikides N, Kaltsas T, et al. Disturbances of menstruation in hypothyroidism. Clin Endocrinol (Oxf). 1999;50:655–9.CrossRefGoogle Scholar
  37. 37.
    Livingstone M, Fraser IS. Mechanisms of abnormal uterine bleeding. Hum Reprod Update. 2002;8:60–7.CrossRefPubMedGoogle Scholar
  38. 38.
    Kaplowitz P. Subclinical hypothyroidism in children: normal variation or sign of a failing thyroid gland? Int J Pediatr Endocrinol. 2010;2010:281453.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Medicine PCotASfR. Current evaluation of amenorrhea. Fertil Steril. 2006;86:S148.Google Scholar
  40. 40.
    Viswanathan V, Eugster E. Etiology and treatment of hypogonadism in adolescents. Pediatr Clin North Am. 2011;58:1181–200.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Samuels MH, Ridgway EC. Central hypothyroidism. Endocrinol Metab Clin North Am. 1992;21:903–19.PubMedGoogle Scholar
  42. 42.
    Prabhakar V, Shalet S. Aetiology, diagnosis, and management of hypopituitarism in adult life. Postgrad Med J. 2006;82:259–66.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Grossman AB. The diagnosis and management of central hypoadrenalism. J Clin Endocrinol Metabol. 2010;95:4855–63.CrossRefGoogle Scholar
  44. 44.
    Mullur R, Liu Y-Y, Brent GA. Thyroid hormone regulation of metabolism. Physiol Rev. 2014;94:355–82.CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Ross J, Czernichow P, Biller BMK, Colao A, Reiter E, Kiess W. Growth hormone: health considerations beyond height gain. Pediatrics. 2010;125:e906–18.CrossRefPubMedGoogle Scholar
  46. 46.
    Emons J, Chagin AS, Sävendahl L, Karperien M, Wit JM. Mechanisms of growth plate maturation and epiphyseal fusion. Horm Res Paediatr. 2011;75:383–91.CrossRefPubMedGoogle Scholar
  47. 47.
    DiVasta A, Gordon C. Hormone replacement therapy and the adolescent. Curr Opin Obstet Gynecol. 2010;22:363–8.CrossRefPubMedGoogle Scholar
  48. 48.
    Mancini T, Casanueva FF, Giustina A. Hyperprolactinemia and prolactinomas. Endocrinol Metab Clin North Am. 2008;37:67–99.CrossRefPubMedGoogle Scholar
  49. 49.
    Herman V et al. Clonal origin of pituitary adenomas. J Clin Endocrinol Metabol. 1990;71:1427–33.CrossRefGoogle Scholar
  50. 50.
    Saranac L, Zivanovic S, Radovanovic Z, Kostic G, Markovic I. Hyperprolactinemia: different clinical expression in childhood. Horm Res Paediatr. 2010;73:187–92.CrossRefPubMedGoogle Scholar
  51. 51.
    Halac I, Zimmerman D. Endocrine manifestations of craniopharyngioma. Childs Nerv Syst. 2005;21:640–8.CrossRefPubMedGoogle Scholar
  52. 52.
    Molitch ME. Drugs and prolactin. Pituitary. 2008;11:209–18.CrossRefPubMedGoogle Scholar
  53. 53.
    Snyder PJ, Jacobs LS, Utiger RD, Daughaday WH. Thyroid hormone inhibition of the prolactin response to thyrotropin-releasing hormone. J Clin Invest. 1973;52:2324–9.CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Wang AT et al. Treatment of hyperprolactinemia: a systemic review and meta-analysis. Syst Rev. 2012;1:33.CrossRefPubMedPubMedCentralGoogle Scholar
  55. 55.
    Webster J, Piscitelli G, Polli A, Ferrari CI, Ismail I, Scanlon MF. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. N Engl J Med. 1994;331:904–9.CrossRefPubMedGoogle Scholar
  56. 56.
    Shibli-Rahhal A, Schlecte J. Hyperprolactinemia and infertility. Endocrinol Metab Clin North Am. 2011;40:837–46.CrossRefPubMedGoogle Scholar
  57. 57.
    Melmed S, Kleinberg D. Pituitary masses and tumors. In: Melmed S, Polonsky K, Larsen R, Kronenberg H, editors. Williams textbook of endocrinology. 12th ed. Philadelphia: Elsevier Saunders; 2011. p. 229–90.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  • Allison Bauman
    • 1
  • Laura Novello
    • 1
  • Paula Kreitzer
    • 2
    • 3
  1. 1.Division of Pediatric EndocrinologyCohen Children’s Medical Center of New York/Long Island Jewish Medical CenterLake SuccessUSA
  2. 2.Division of Pediatric EndocrinologyCohen Children’s Medical Center of New York/Long Island Jewish Medical CenterLake SuccessUSA
  3. 3.Hofstra Northwell School of MedicineHempsteadUSA

Personalised recommendations